124 related articles for article (PubMed ID: 8322787)
21. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein (a) levels and clinical correlations in CAPD patients.
Lye WC; Hughes K; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():131-3. PubMed ID: 8534686
[TBL] [Abstract][Full Text] [Related]
23. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
24. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
[TBL] [Abstract][Full Text] [Related]
25. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
[TBL] [Abstract][Full Text] [Related]
26. Mechanism for elevated plasma lipoprotein(a) concentrations in patients on dialysis: turnover studies.
Misra M; Reaveley DA; Cooper C; Brown EA; Knight BL; Wade D; Seed M
Adv Perit Dial; 1998; 14():223-7. PubMed ID: 10649729
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein(a) in chronic renal disease.
Stenvinkel P; Berglund L
Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
Babazono T; Miyamae M; Tomonaga O; Omori Y
Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
Levine DM; Gordon BR
Am J Kidney Dis; 1995 Jul; 26(1):162-9. PubMed ID: 7611248
[TBL] [Abstract][Full Text] [Related]
30. Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.
Al-Saady NM; Leatham EW; Gupta S; Kwan JT; Eastwood JB; Seymour CA
Heart; 1999 Feb; 81(2):134-40. PubMed ID: 9922347
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
32. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.
Gault MH; Longerich LL; Purchase L; Harnett J; Breckenridge C
Nephron; 1995; 70(2):155-70. PubMed ID: 7566298
[TBL] [Abstract][Full Text] [Related]
34. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
Anwar N; Bhatnagar D; Short CD; Mackness MI; Durrington PN; Prais H; Gokal R
Nephrol Dial Transplant; 1993; 8(1):71-4. PubMed ID: 8381941
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
Nephrol Dial Transplant; 1993; 8(7):609-13. PubMed ID: 8396744
[TBL] [Abstract][Full Text] [Related]
37. Increased serum apolipoprotein(a) in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis.
Murphy BG; McNamee P; Duly E; Henry W; Archbold P; Trinick T
Atherosclerosis; 1992 Mar; 93(1-2):53-7. PubMed ID: 1596303
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation.
Irish AB; Simons LA; Savdie E; Hayes JM; Simons J
Aust N Z J Med; 1992 Jun; 22(3):243-8. PubMed ID: 1386727
[TBL] [Abstract][Full Text] [Related]
39. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
40. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.
Podrez EA; O'Neil J; Salomon RG; Schreiber MJ; Hoff HF
Kidney Int; 1998 Aug; 54(2):637-45. PubMed ID: 9690232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
